miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s210732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Correction: Cisplatin-Induced Epigenetic Activation of miR-34a Sensitizes Bladder Cancer Cells to Chemotherapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

miR-124 Inhibits the Growth of Glioblastoma Through the Downregulation of SOS1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2013English

Reactivation of Epigenetically Silenced miR-512 and miR-373 Sensitizes Lung Cancer Cells to Cisplatin and Restricts Tumor Growth

Cell Death and Differentiation
Cell BiologyMolecular Biology
2015English

Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma via Targeting MGMT

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2020English

Up-Regulation of miR-370-3p Restores Glioblastoma Multiforme Sensitivity to Temozolomide by Influencing MGMT Expression

Scientific Reports
Multidisciplinary
2016English

Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition

Oncology Reports
MedicineCancer ResearchOncology
2019English

MiR-338-3p Regulates Neuronal Maturation and Suppresses Glioblastoma Proliferation

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy